NPPA Caps Retail Prices Of 39 Drug Formulations For Diabetes, Heart Disease, Hypertension
Under DPCO 2013, NPPA has fixed ceiling prices on 39 formulations spanning diabetes, hypertension and cardiac care. Pharmacy retailers must sell at or below government-set rates, compressing retail margins and lowering consumer prices with immediate effect.
NPPA capped retail prices of 39 drug formulations for diabetes, hypertension, heart disease and other conditions under DPCO 2013. Pharmacy retailers must sell at or below government-fixed prices, affecting pharmacy-retail margins and consumer pricing.
Why this matters
NPPA extends its price-control push after recently capping 30 formulations across diabetes, BP, heart and antibiotics. The new order on 39 formulations signals sustained margin pressure on pharmacy retailers.
Retail-company signals accelerating at +724500% QoQ.